• Title/Summary/Keyword: High Dose Rate

Search Result 878, Processing Time 0.022 seconds

Development of a Pelvic Phantom for Dose Verification in High Dose Rate (HDR) Brachytherapy

  • Jang, Ji-Na;Suh, Tae-Suk;Huh, Soon-Nyung;Kim, Hoi-Nam;Yoon, Sei-Chul;Lee, Hyoung-Koo;Choe, Bo-Young
    • Proceedings of the Korean Society of Medical Physics Conference
    • /
    • 2002.09a
    • /
    • pp.150-153
    • /
    • 2002
  • High dose rate (HDR) brachytherapy in the treatment of cervix carcinoma has become popular, because it eliminated many of the problems with conventional brachytherapy. In order to improve clinical effectiveness with HDR brachytherapy, dose calculation algorithm, optimization procedures, and image registrations should be verified by comparing the dose distributions from a planning computer and those from a humanoid phantom irradiated. Therefore, the humanoid phantom should be designed such that the dose distributions could be quantitatively evaluated by utilizing the dosimeters with high spatial resolution. Therefore, the small size of thermoluminescent dosimeter (TLD) chips with the dimension of 1/8" and film dosimetry with spatial resolution of <1mm used to measure the radiation dosages in the phantom. The humanoid phantom called a pelvic phantom is made of water and tissue-equivalent acrylic plates. In order to firmly hold the HDR applicators in the water phantom, the applicators are inserted into the grooves of the applicator supporters. The dose distributions around the applicators, such as Point A and B, can be measured by placing a series of TLD chips (TLD-to- TLD distance: 5mm) in three TLD holders, and placing three verification films in orthogonal planes.

  • PDF

Variation of optimization techniques for high dose rate brachytherapy in cervical cancer treatment

  • Azahari, Ahmad Naqiuddin;Ghani, Ahmad Tirmizi;Abdullah, Reduan;Jayamani, Jayapramila;Appalanaido, Gokula Kumar;Jalil, Jasmin;Aziz, Mohd Zahri Abdul
    • Nuclear Engineering and Technology
    • /
    • v.54 no.4
    • /
    • pp.1414-1420
    • /
    • 2022
  • High dose rate (HDR) brachytherapy treatment planning usually involves optimization methods to deliver uniform dose to the target volume and minimize dose to the healthy tissues. Four optimizations were used to evaluate the high-risk clinical target volume (HRCTV) coverage and organ at risk (OAR). Dose-volume histogram (DVH) and dosimetric parameters were analyzed and evaluated. Better coverage was achieved with PGO (mean CI = 0.95), but there were no significant mean CI differences than GrO (p = 0.03322). Mean EQD2 doses to HRCTV (D90) were also superior for PGO with no significant mean EQD2 doses than GrO (p = 0.9410). The mean EQD2 doses to bladder, rectum, and sigmoid were significantly higher for NO plan than PO, GrO, and PGO. PO significantly reduced the mean EQD2 doses to bladder, rectum, and sigmoid but compromising the conformity index to HRCTV. PGO was superior in conformity index (CI) and mean EQD2 doses to HRCTV compared with the GrO plan but not statistically significant. The mean EQD2 doses to the rectum by PGO plan slightly exceeded the limit from ABS recommendation (mean EQD2 dose = 78.08 Gy EQD2). However, PGO can shorten the treatment planning process without compromising the CI and keeping the OARs dose below the tolerance limit.

The Treatment of Uterine Cervical Cancer Using High Dose Rate Co-60 Sources (고선량율(高線量率) 강내조사법(腔內照射法)을 이용(利用)한 자궁경암(子宮頸癌) 방사선(放射線) 치료(治療))

  • Kim, G.E.;Suh, C.O.;Lee, D.H.;Park, C.Y.
    • Radiation Oncology Journal
    • /
    • v.1 no.1
    • /
    • pp.95-102
    • /
    • 1983
  • The radical treatment of uterine cervical cancer by interacavitary radium or cesium, in combination with teletherapy are well known. Although the result of such treatment should not give rise to complacency, problem of radiation exposure to medical staff had not been resolved. Fortunately, many attempts have been made to reduce this hazard, most of which take the form of afterloading applicators with a suitably shielded radioisotope. In order to avoid hazardous radiation exposure to staffs concerned with brachytherapy, RALS using high intensity source of Co-60, have been employed at Yonsei Cancer Center since May, 1979. It allows rectal and bladder doses to be kept low, while maintaining a satifactory usual dose distribution of the other type of applicators, and the short treatment time allow four or five patients to be treated per hour. It also removes much patient's discomfort and the difficulties of nursing these patients. Since the first introduction in Korea, over seven hundred cases with various stage of uterine cervical cancer have been treated on a radical basis at this center last 4 years. These authors have strongly attracted attention to the results in terms of local control rate, survival s and morbidity compared with those of conventional low dose rate radiotherapy. Retrospective interim analysis of data was preliminarily accomplished through the labored follow-up study of 340 cases treated during initial 2 years and the radiobiologic standpoint of high dose rate intracavitary irradiation will be discussed.

  • PDF

Clinical outcome of high-dose-rate interstitial brachytherapy in patients with oral cavity cancer

  • Lee, Sung Uk;Cho, Kwan Ho;Moon, Sung Ho;Choi, Sung Weon;Park, Joo Yong;Yun, Tak;Lee, Sang Hyun;Lim, Young Kyung;Jeong, Chi Young
    • Radiation Oncology Journal
    • /
    • v.32 no.4
    • /
    • pp.238-246
    • /
    • 2014
  • Purpose: To evaluate the clinical outcome of high-dose-rate (HDR) interstitial brachytherapy (IBT) in patients with oral cavity cancer. Materials and Methods: Sixteen patients with oral cavity cancer treated with HDR remote-control afterloading brachytherapy using $^{192}Ir$ between 2001 and 2013 were analyzed retrospectively. Brachytherapy was administered in 11 patients as the primary treatment and in five patients as salvage treatment for recurrence after the initial surgery. In 12 patients, external beam radiotherapy (50-55 Gy/25 fractions) was combined with IBT of 21 Gy/7 fractions. In addition, IBT was administered as the sole treatment in three patients with a total dose of 50 Gy/10 fractions and as postoperative adjuvant treatment in one patient with a total of 35 Gy/7 fractions. Results: The 5-year overall survival of the entire group was 70%. The actuarial local control rate after 3 years was 84%. All five recurrent cases after initial surgery were successfully salvaged using IBT ${\pm}$ external beam radiotherapy. Two patients developed local recurrence at 3 and 5 months, respectively, after IBT. The acute complications were acceptable (${\leq}grade$ 2). Three patients developed major late complications, such as radio-osteonecrosis, in which one patient was treated by conservative therapy and two required surgical intervention. Conclusion: HDR IBT for oral cavity cancer was effective and acceptable in diverse clinical settings, such as in the cases of primary or salvage treatment.

Performance Evaluation of Lab-scale High Rate Coagulation System for CSOs Treatment (강우유출수의 신속한 처리를 위한 고속응집시스템의 성능 평가 -실험실 규모 장치를 중심으로-)

  • Gwon, Eun-Mi;Oh, Seok-Jin;Cho, Seong-Ju;Lee, Seng-Chul;Ha, Sung-Ryong;Lim, Chea-Hoan;Park, Ji-Hoon;Kang, Seon-Hong
    • Journal of Korean Society of Water and Wastewater
    • /
    • v.24 no.5
    • /
    • pp.629-639
    • /
    • 2010
  • To evaluate the performance of high rate coagulation system(HRCS) for CSOs treatment, fundamental function of lab scale HRCS has been tested by using the Jar tester and lab scale HRCS. The optimum pH dose by Streaming Current value was found in the range of 5.3~6.0 in Fe(III), and in the range of 5.8~6.6 in Al(III) and the optimum chemical dose were 0.44mM of $Al_2(SO_4)_3$ and 0.93mM of $FeCl_3$. The removal efficiencies at optimum $Al_2(SO_4)_3$ dose were 75%($TCOD_{Cr}$), 97%(TP), 95%(SS) and 96%(turbidity), respectively. And the removal efficiency of particles with less than $5{\mu}m$ of diameter was 70% and that of particles with higher than $5{\mu}m$ of diameter was 90%. The optimum alum dose in lab scale HRCS was 150mg/L, and the treatment efficiency was the best with addition of 1.0mg/L polymer. The effect of Micro sand addition was not clear, because the depth of the sediment tank in lab scale HRCS was not long enough. But the HRT of this lab scale HRCS was able to be shorten less then 7 minutes by adding the micro sand. The surface loading rates with respect to using different chemicals were 0.43m/h with alum only, 5.78m/h with alum and polymer and 6.22m/h with alum, polymer and micro sand. As a result, HRCS using coagulant, polymer and micro sand developed in this study was evaluated to be very effective for CSOs treatment.

HIGH DOSE RATE BRACHYTHERAPY IN PRIMARY AND RECURRENT TONGUE CANCER (고선량율 근접 방사선치료법을 이용한 원발성 및 재발된 설암의 치료)

  • Lee, Ui-Lyong;Lee, Jong-Ho;Choung, Pill-Hoon;Kim, Myung-Jin;Park, Joo-Yong;Choi, Sung-Weon;Cho, Kwan-Ho
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • v.28 no.5
    • /
    • pp.470-476
    • /
    • 2006
  • Low-dose rate brachytherapy(LDR) has been effective modality for treatment of oral cancer. But the disadvantage of LDR is radioexposure of medical staff. To overcome this problem, high dose rate(HDR) brachytherapy has been developed. Our study evaluates the outcomes of patients with tongue cancer as treated by HDR brachytherapy. Between 2002 and 2005, eight patients with carcinoma of the tongue were treated with HDR brachytherapy. Five patients had AJCC stage I or II disease and the remaining three patients had AJCC stage III or IV. The male-to-female ratio was 2:6 and the mean age was 60.1 years (range: 21-80 years).The median follow-up time was 23.8 months (range: 7-55 months). There was no local failure until now. Three patients showed some complications. Two patients showed soft tissue necrosis. There was no bone sequela in all cases. Our experience in treating tongue cancer with HDR brachytherapy is encouraging, because it gave a satisfactory local control. Prospective studies are necessary to delineate the optimum indication for this treatment modality and long-term outcome.

Efficacy of Low Dose Barbiturate Coma Therapy for the Patients with Intractable Intracranial Hypertension Using the $Bispectral^{TM}$ Index Monitoring

  • An, Hung-Shik;Cho, Byung-Moon;Kang, Jeong-Han;Kim, Moon-Kyu;Oh, Sae-Moon;Park, Se-Hyuck
    • Journal of Korean Neurosurgical Society
    • /
    • v.47 no.4
    • /
    • pp.252-257
    • /
    • 2010
  • Objective : Barbiturate coma therapy (BCT) is a useful method to control increased intracranial pressure (IICP) patients. However, the complications such as hypotension and hypokalemia have caused conditions that stopped BCT early. The complications of low dose BCT with $Bispectral^{TM}$ index (BIS) monitoring and those of high dose BCT without BIS monitoring have been compared to evaluate the efficacy of low dose BCT with BIS monitoring. Methods : We analyzed 39 patients with high dose BCT group (21 patients) and low dose BCT group (18 patients). Because BIS value of 40-60 is general anesthesia score, we have adjusted the target dose of thiopental to maintain the BIS score of 40-60. Therefore, dose of thiopental was kept 1.3 to 2.6 mg/kg/hour during low dose BCT. However, high dose BCT consisted of 5 mg/kg/hour without BIS monitoing. Results : The protocol of BCT was successful in 72.2% and 38.1% of low dose and high dose BCT groups, respectively. The complications such as QT prolongation, hypotension and cardiac arrest have caused conditions that stopped BCT early. Hypokalemia showed the highest incidence rate in complications of both BCT. The descent in potassium level were $0.63{\pm}0.26$ in low dose group, and $1.31{\pm}0.48$ in high dose group. The treatment durations were $4.89{\pm}1.68$ days and $3.38{\pm}1.24$ days in low dose BCT and high dose BCT, respectively. Conclusion : It was proved that low dose BCT showed less severe complications than high dose BCT. Low dose BCT with BIS monitoring provided enough duration of BCT possible to control ICP.

Degradation of residual pharmaceuticals in water by UV/H2O2 advanced oxidation process (UV/H2O2 고도산화기술을 이용한 수중 잔류의약물질 제거)

  • Park, Chinyoung;Seo, Sangwon;Cho, Ikhwan;Jun, Yongsung;Ha, Hyunsup;Hwang, Tae-Mun
    • Journal of Korean Society of Water and Wastewater
    • /
    • v.33 no.6
    • /
    • pp.469-480
    • /
    • 2019
  • This study was conducted to evaluate the degradation and mineralization of PPCPs (Pharmaceuticals and Personal Care Products) using a CBD(Collimated Beam Device) of UV/H2O2 advanced oxidation process. The decomposition rate of each substance was regarded as the first reaction rate to the ultraviolet irradiation dose. The decomposition rate constants for PPCPs were determined by the concentration of hydrogen peroxide and ultraviolet irradiation intensity. If the decomposition rate constant is large, the PPCPs concentration decreases rapidly. According to the decomposition rate constant, chlortetracycline and sulfamethoxazole are expected to be sufficiently removed by UV irradiation only without the addition of hydrogen peroxide. In the case of carbamazepine, however, very high UV dose was required in the absence of hydrogen peroxide. Other PPCPs required an appropriate concentration of hydrogen peroxide and ultraviolet irradiation intensity. The UV dose required to remove 90% of each PPCPs using the degradation rate constant can be calculated according to the concentration of hydrogen peroxide in each sample. Using this reaction rate, the optimum UV dose and hydrogen peroxide concentration for achieving the target removal rate can be obtained by the target PPCPs and water properties. It can be a necessary data to establish design and operating conditions such as UV lamp type, quantity and hydrogen peroxide concentration depending on the residence time for the most economical operation.

Analysis of High Dose Rate Intracavitary Radiotherapy(HDR-ICR) Treatment Planning for Uterine Cervical Cancer (자궁경부암의 고선량율 강내치료 선량계획 분석)

  • Chai, Gyu-Young
    • Radiation Oncology Journal
    • /
    • v.12 no.3
    • /
    • pp.387-392
    • /
    • 1994
  • Purpose : This study was done to confirm the reference point variation according to variation in applicator configuration in each fractioation of HDR ICR. Materials and Methods : We analyzed the treatment planning of HDRICR for 33 uterine cervical cancer patients treated in department of therapeutic radiology from January 1992 to February 1992. Analysis was done with respect to three view points-Interfractionation A point variation, interfractionation bladder and rectum dose ratio variation, interfractionation treatment volume variation. Interfractionation A point variation was defined as difference between maximum and minimum distance from fixed rectal point to A point in each patient. Interfractionation bladder and rectum dose ratio variation was defined as difference between maximum and minimum dose ratio of bladder or rectum to A point dose in each patient, Interfractionation treatment volume variation was defined as difference between miximum and minimum treatment volume which absorbed over the described dose-that is, 350 cGy or 400 cGy-in each patient. Results The mean of distance from rectum to A point was 4.44cm, and the mean of interfractionation distance variation was 1.14 cm in right side,1.09 cm in left side. The mean of bladder and rectum dose ratio was $63.8\%$ and $63.1\%$ and the mean of interfractionation variation was $14.9\%$ and $15.8\%$ respectively. With fixed planning administration of same planning to all fractionations as in first fractionation planning-mean of bladder and rectum dose ratio was $64.9\%$ and $72.3\%$.and the mean of interfraction variation was $28.1\%$ and $48.1\%$ reapectively. The mean of treatment volume was $84.15cm^3$ and the interfractionation variation was $21.47cm^2$. Conclusion : From these data, it was confirmed that there should be adapted planning for every fractionation ,and that confirmation device installed in ICR room would reduce the interfractionation variation due to more stable applicator configuration.

  • PDF

A Dual Radiation Monitoring System Ror Robot Working in High Radiation Field (고방사선장내 작업 로봇용 이중 방사선 감지 시스템)

  • Lee Nam-Ho;Cho Jai-Wan;Kim Seung-Ho
    • The Transactions of the Korean Institute of Electrical Engineers D
    • /
    • v.54 no.9
    • /
    • pp.556-558
    • /
    • 2005
  • The effect of high irradiation on inspection systems in a nuclear power plant can be severe, especially to electronic components such as control hoards. The effect may lead to a critical malfunction or trouble to a underwater robot for inspection and maintenance of nuclear reactor. However, if information on the total accumulated dose on the sensitive parts of the robot is available, a prediction of robot's behavior in radiation environments becomes possible. To know how much radiation the robot has encountered, a dosimeter to measure the total accumulated dose is necessary. This paper describes the development effort of a dual radiation monitoring system using a SiC diode as a dose-rate meter and a p-type power MOSFET as a dose meter. This attempt using two sensors which detect same radiation improves reliability and stability at high intensity radiation detection in nuclear facilities. It uses the concept of diversity and redundancy.